Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • Euretina 2026 Vienna
      • On-Demand
      • Welcome
      • Congress Daily
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Programme
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Ramin Tadayoni Award
    • Mentorship Programme
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • Euretina 2026 Vienna
      • On-Demand
      • Welcome
      • Congress Daily
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Programme
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Ramin Tadayoni Award
    • Mentorship Programme
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Atypical mycobacterial retinitis in a young patient of retroviral disease

Author: Satabdi Nanda (India)

Co-authors: Keerti Mukesh, Kalpana Babu Murthy, Krishna R. Murthy, Dhwani Shah, Vinay Kumar Konana

Purpose

To describe a presentation of retinitis due to atypical mycobacterium subspecies Mycobacterium abscessus in a patient with Retroviral disease.Atypical mycobacteria are Mycobacteria other than Mycobacterium tuberculosis.They are opportunistic free living pathogens.Group IV, the rapid growers(according to Runyon’s Classification) -Mycobacterium abscessus, M. chelonae and M. fortuitum have been reported to be responsible for majority of the ocular infections caused by atypical mycobacteria.Risk factors include trauma, previous corneal infection or surgery, corticosteroid use and systemic immunosuppression. Laboratory detection, clinical diagnosis and management of ocular infections caused by atypical mycobacteria are quite challenging. Our purpose is to highlight the importance of cytology and culture in the diagnosis of these cases especially in immunocompromised patients who are more likely to develop intraocular atypical mycobacterial infections, which are associated with a greater risk of loss of vision.

Setting/Venue

Clinical case report from a tertiary eye care hospital in South India. A 17 year old male was referred to us from a higher paediatric centre with complaints of progressive diminution of vision in both eyes,left more than right,since 6 months. He was under ATT (Isoniazid, Rifampicin, Pyrazinamide) since 2.5years and Anti-Retroviral therapy (Tenofovir, Lamivudine, Dolutegravir) since 1 year. Chest X-ray done at this point in time was clear. CSF analysis (microscopy, culture & PCR) for MTB was negative in presence of mild pleocytosis. Under the advice to continue ATT and ART, he was referred for ophthalmological evaluation.

Methods

At the time of presentation, his CD4 count was 280.BCVA was 6/18P in OD and 6/9 in OS. Anterior segment examination OU revealed medium sized keratic precipitates, grade 2+ AC cells and posterior subcapsular cataract. Fundus examination showed vitritis of grade 2+ and multiple confluent, creamy yellowish white lesions in the periphery suggesting retinitis. IOP was 14mm of Hg in OU. He was investigated to rule out syphilis, toxoplasmosis, viral and endogenous endophthalmitis.Antibodies to Toxoplasma in blood and CSF, HCV, HBSAg and VDRL were negative. CBNAAT for TB was negative. CSF culture was positive for Cryptococcus on Indian Ink preparation which was surprising given the decent CD4 counts. After receiving IV Amphotericin B for 12 days, Oral Fluconazole 225 mg/day and Oral TMP-SMX, along with topical steroids and homide, the retinitis remained status quo with increased vitritis in the left eye. BCVA was 6/12p(OD) and 6/18(OS). In view of increasing vitritis in OS, he was administered single intravitreal injection of amphotericin B(5mcg/0.1ml). The following day, there was a significant worsening of vision to 6/24P with hypopyon in AC, dense vitritis, and increased retinitis in OS, raising suspicion of toxic reaction to Amphotericin B or secondary bacterial endophthalmitis.

Results

Intravitreal injection of Vancomycin and Ceftazidime was given to OS. AC tap sample was sent for Gram’s stain, KOH stain, PCR to rule out bacterial(including mycobacteria) and viral pathology,which was inconclusive. 2 days following the injection,vision dropped to CFCF with worsening of vitreous haze.He underwent pars plana vitrectomy in OS with intravitreal injections of Vancomycin, Amikacin and Voriconazole.Vitreous aspirate was sent for cytology, PCR( eubacterial, panfungal, viral & mycobacterial species) and Culture( Bacterial, fungal & Mycobacterial). On Postoperative day 1, vision was 6/24 with resolution of hypopyon. Cytology revealed granulomatous picture with few AFB suggestive of tubercular etiology. Mycobacterium abcessus was isolated on culture, which was sensitive to Imipenem, Azithromycin, Clarithromycin, Amikacin, Tobramycin and Gatifloxacin. He was started on Tab Azithromycin 500mg per day. OU received Intravitreal Amikacin injection(125mcg/0.1ml) following which retinitis showed signs of gradual resolution and consolidation. He received further injections of intravitreal amikacin (total of five in each eye). Intravenous Meropenem 1g injections thrice a day was given for 6 weeks based on sensitivity profile. He was followed up over four months and is doing well with BCVA of 6/9 in OU. We plan to continue periodic follow ups with meticulous examination.

Conlusions

Atypical mycobacterial infections are rare but can lead to serious vision-threatening complications.Management is challenging as the retinitis is usually attributed to other causes such as viral or fungal infection.In this case, presentation of granulomatous KP’s with retinitis was unusual in an immunocompromised patient with decent CD4 counts. CSF culture was positive for Cryptococcus but vision and retinitis worsened with anti fungal treatment.Multiple PCR did not reveal the causative agent. Vitreous aspirate revealed AFB and culture detected Mycobacterium abcessus.Patient received multiple intravitreal Amikacin injections and IV Meropenem which caused a dramatic improvement in vision and resolution of retinitis. In 2015, Kheir et al reported that more than half of endogenous endophthalmitis cases were associated with immunodeficiency status.Pinitpuwadol, Warinyupa et al in 2020 reported that M.abscessus was associated with poor visual outcome with majority of cases ending up with visual impairment, evisceration or phthisis.High index of suspicion is necessary.Repeated vitreous and aqueous cultures are required to identify causative organism.Treatment includes combination of local and systemic antibiotics based on drug sensitivity. Anti tuberculosis drugs are commonly prescribed.Amikacin, clarithromycin and azithromycin are considered to be the best antibiotics for these infections.Intravenous Amikacin and Imipenem have been reported to be successful in the management.

Financial Disclosure

NIL

Comments

-
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

European Society of Retina Specialists c/o Congrex Switzerland
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

General Enquires: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • Euretina 2026 Vienna
      • On-Demand
      • Welcome
      • Congress Daily
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Euretina Innovation Spotlight (EIS) 2026
      • General Information
      • Registration
      • Programme
      • Contributors
      • Companies
      • Application for Emerging Companies
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Programme
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Ramin Tadayoni Award
    • Mentorship Programme
      • Mentorship Alumni
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login